My research aims to understand why some melanomas stop responding to treatments over time and to identify new ways to make these therapies more effective. By studying how cancer cells adapt and survive under drug pressure, I hope to uncover the molecular “escape routes” that tumors use and to develop drug combinations capable of preventing or reversing resistance. The ultimate goal is to translate these findings into more durable and effective therapies for melanoma patients.